Canadian Consortium Extends Funding for Drug Research - - BioPharm International

ADVERTISEMENT

Canadian Consortium Extends Funding for Drug Research


Ontario Centres of Excellence (OCE) and the Ontario Brain Institute (OBI) have announced a partnership with CQDM to bring an additional $3 million to two programs dedicated to breakthrough technologies to accelerate drug discovery and development.

With an investment of $500,000, OCE is joining CQDM in launching the 2014 edition of CQDM’s Explore Program to fund the Ontario arm. The initiative fosters innovative and unconventional game-changing biopharmaceutical research. This is the first time this program will be open to researchers in Ontario as well as in Quebec, thanks to the partnership with OCE.

With a commitment of up to $2.5 million, OBI embarks with CQDM and Brain Canada on the new national initiative in neuroscience Focus on Brain. OBI¹s contribution thus brings to $12.5 million the total funding available to researchers in academia as well as SMEs across Canada, for the development of breakthrough technologies to accelerate the discovery of drugs for disorders of the brain and nervous system. OBI’s funding will be dedicated to Ontario-based entities.

CQDM is a pharma-based consortium active in pre-competitive research whose mission is to fund the development of innovative tools and technologies to accelerate drug discovery and development.

Source: CDQM

 

 

blog comments powered by Disqus

ADVERTISEMENT

ADVERTISEMENT

Pfizer to Acquire Vaccines from Baxter
July 30, 2014
GSK Submits EU Regulatory Filing for Malaria Vaccine Candidate
July 29, 2014
Bristol-Myers Squibb and Ono Pharmaceutical Collaborate on Immunotherapies
July 28, 2014
FDA Accepts First Biosimilar Filing
July 24, 2014
Compounding Pharmacy Issues Recall, But Challenges FDA Decision
July 22, 2014
Author Guidelines

Click here